Transdermal Patch Indica 10pk
$75.00
- 10 transdermal patches per pack
- Each patch delivers 20 mg THC (200 mg total per pack)
- Provides 8–12 hours of systemic relief
- Indica formulation enriched with B-Myrcene, B-Pinene, B-Caryophyllene, and Linalool
- Utilizes transdermal delivery technology for efficient absorption
14 in stock
Brand
Mary's Medicinals is a trusted leader in cannabis-derived wellness products, committed to enhancing lives with plant-based, scientifically advanced solutions. With a focus on merging modern technology with natural horticultural practices, Mary’s offers patients an alternative to traditional medicine through innovative cannabis therapies. Collaborating with top scientists and physicians, they create products that promote body and mind wellness, utilizing clean, efficient delivery systems like transdermal patches, gels, and capsules for precise dosing and sustained effects. Their mission is to distill the wisdom of plants into targeted therapies that empower individuals to take control of their health.
You must be logged in to post a review.
Related products
-
Sale!

Fire And Ice Max
420 - 25% OffFire And Ice Max
AlternativeTHC 1000mg CBD 1000mg$60$45 / 1000mg0 out of 5$60.00Original price was: $60.00.$45.00Current price is: $45.00. Add to cart -

Transdermal Patch Indica
Transdermal Patch Indica
IndicaTHC 18mg$13 / 18mg0 out of 5$13.00 Add to cart -
Sale!

Fire And Ice Max Single
420 - 25% OffFire And Ice Max Single
AlternativeTHC 191mg$4$3 / 191mg0 out of 5$4.00Original price was: $4.00.$3.00Current price is: $3.00. Add to cart -

Transdermal Patch CBD/THC 1:1
Transdermal Patch CBD/THC 1:1
AlternativeTHC 9mg CBD 10mg$13 / 9mg0 out of 5$13.00 Add to cart -

Transdermal Compound 1:1 CBD:THC 500mg
Transdermal Compound 1:1 CBD:THC 500mg
5.00 out of 5AlternativeTHC 250mg CBD 250mg$36 / 250mg5.00 out of 5$36.00 Add to cart -

Transdermal Patch CBD/THC 1:1 10pk
Transdermal Patch CBD/THC 1:1 10pk
AlternativeTHC 100mg CBD 100mg$75 / 100mg0 out of 5$75.00 Add to cart
Reviews
There are no reviews yet.